IMPACCT: mHealth

@mHealth_Trials

A disruptive meeting that looks to overcome the operational and regulatory challenges in implementation and adoption in clinical trials.

Boston, MA
impacct-mhealth.com
Geregistreerd in februari 2017
10 foto's en video's Foto's en video's

Tweets

Je hebt @mHealth_Trials geblokkeerd

Weet je zeker dat je deze Tweets wilt bekijken? @mHealth_Trials wordt niet gedeblokkeerd door Tweets te bekijken.

  1. heeft geretweet
    22 jun.

    First continuous glucose monitoring system that includes a fully implantable glucose sensor that can be worn up to 90 days approved today.

    1 antwoord 11 retweets 14 vind-ik-leuks
    Ongedaan maken
  2. heeft geretweet
    14 jun.

    ActiGraph is a proud sponsor of , a meeting focused on overcoming challenges of and -enabled .

    1 antwoord 2 retweets 4 vind-ik-leuks
    Ongedaan maken
  3. 20 jun.

    Changing the way medicines are developed - interesting insights on from Roche.

    1 retweet
    Ongedaan maken
  4. heeft geretweet
    19 jun.

    . just launched the next version of our precertification pilot program working model. Help us as we build this program from the ground up by providing your feedback at this critical stage:

    2 antwoorden 8 retweets 10 vind-ik-leuks
    Deze collectie tonen
    Deze collectie tonen
    Ongedaan maken
  5. 18 jun.

    The energy is building up for our 3rd annual IMPACCT: mHealth 2018 meeting! Join us in Boston for a pre-conference focused workshop day on July 10, and 2 days of comprehensive learning and sharing on in (July 11-12)! Join today!

    1:28
    I am truly excited to be speaking . My session : Emerging Technologies - True Potential in Clinical Trials. If you wish to connect in let me know.
    3 retweets 3 vind-ik-leuks
    Ongedaan maken
  6. 13 jun.

    Only 4 weeks left to go for our annual meeting in Boston! I hope you can join us!

    1 retweet 1 vind-ik-leuk
    Ongedaan maken
  7. 13 jun.

    New FDA draft guidance on patient-focused drug development !

    Statement from FDA Commissioner on new agency efforts to advance the patient voice in medical product development and FDA regulatory decision-making
    Ongedaan maken
  8. heeft geretweet
    11 jun.

    While holds the potential to improve clinical research, only 37% of companies involved in clinical trials currently use it: (via survey)

    9 retweets 15 vind-ik-leuks
    Ongedaan maken
  9. 31 mei

    Last change to save up to $500 in your registration to attend IMPACCT:mHealth 2018! Special discount expires tomorrow, June 1. Join us to 'impacct' and innovate with !

    1 vind-ik-leuk
    Ongedaan maken
  10. 29 mei

    Hoping to see everyone there in July (Boston) for this exciting meeting! Thanks to Craig for the amazing support he gave us to develop this year's IMPACCT:mHealth!

    Looks like a great event if you have some space for learning in your calendar this July. Excellent speaker line-up to learn and share what's going on with mHealth tools across medicine development.
    1 retweet
    Ongedaan maken
  11. 24 mei

    Following the international , IMPACCT:mHealth wanted to shout out for all organizations working to bring innovation to clinical trials. We will continue to celebrate these endeavors fully in July, with exciting discussions. Join us!

    1 vind-ik-leuk
    Ongedaan maken
  12. 17 mei

    is joining us at IMPACCT:mHealth (July 10-12, Boston)! Learn more about their work in and in from CTO, Jeremy Wyatt, who will be presenting on "The Technology & Supporting Ecosystem Behind Novel Digital Endpoints"

    Conference season is almost here! If you'll be attending any of these upcoming events, please be sure to join one of our panel discussions or visit our booth to meet the ActiGraph team and get a sneak peek at our upcoming CentrePoint Insight Watch!
    Ongedaan maken
  13. 15 mei

    Coverage for a digital therapeutic!

    We announced today that we signed a contract with to reimburse ! Read more: .
    Ongedaan maken
  14. 14 mei

    Michael J Fox Foundation/Verily collaboration to deepen understanding of Parkinson's Disease through digital health tools. Exciting example of applied in clinical research. MJFF will share their latest in July at IMPACCT:mHealth

    Verily study watches will be supplied to over 800 U.S. participants in the MJFF-led Progression Markers Initiative, a study using standardized methods to collect & biosamples. Read more in about the MJFF/Verily collaboration.
    1 retweet
    Ongedaan maken
  15. 10 mei

    How can disruptive trial models help us meet patients in the real world? Bryan McDowell from , who has joined us at our European sister-meeting in London last month as a speaker, shares his thoughts!

    1 retweet
    Ongedaan maken
  16. 4 mei

    A quick reminder today is the last day to take advantage of early booking rates for IMPACCT:mHealth 2018. More info here . I hope to see you there for exciting timely discussions around clinical innovation and in !

    Ongedaan maken
  17. 3 mei

    Roche’s 1st smartphone digital biomarker results now published: . The study shows the feasibility of smartphone‐based digital and is a great example of meaningful digital biomarkers being captured via remote research studies. Exciting!

    3 retweets 3 vind-ik-leuks
    Ongedaan maken
  18. heeft geretweet
    28 apr.

    announced a series of new initiatives this week to advance digital health technology across our medical product programs

    1 antwoord 17 retweets 32 vind-ik-leuks
    Ongedaan maken
  19. 1 mei

    This week it's your last chance to save a max of $700 in your registration for IMPACCT:mHealth 2018 (). Clinical innovation has no price - so join this exciting forum to collaboratively learn and advance how is transforming !

    1 retweet 1 vind-ik-leuk
    Ongedaan maken
  20. heeft geretweet
    28 apr.

    Towards the digitized clinical trial, without the need for any clinical sites by

    5 antwoorden 96 retweets 143 vind-ik-leuks
    Deze collectie tonen
    Deze collectie tonen
    Ongedaan maken

@mHealth_Trials heeft nog niet getweet.

Het laden lijkt wat langer te duren.

Twitter is mogelijk overbelast of ondervindt een tijdelijke onderbreking. Probeer het opnieuw of bekijk de Twitter-status voor meer informatie.

    Je bent misschien ook geïnteresseerd in

    ·